Tamoxifen Sensitizes Acute Lymphoblastic Leukemia Cells to Cannabidiol by Targeting Cyclophilin-D and Altering Mitochondrial Ca2+ Homeostasis

Int J Mol Sci. 2021 Aug 13;22(16):8688. doi: 10.3390/ijms22168688.

Abstract

Cytotoxic effects of cannabidiol (CBD) and tamoxifen (TAM) have been observed in several cancer types. We have recently shown that CBD primarily targets mitochondria, inducing a stable mitochondrial permeability transition pore (mPTP) and, consequently, the death of acute lymphoblastic leukemia (T-ALL) cells. Mitochondria have also been documented among cellular targets for the TAM action. In the present study we have demonstrated a synergistic cytotoxic effect of TAM and CBD against T-ALL cells. By measuring the mitochondrial membrane potential (ΔΨm), mitochondrial calcium ([Ca2+]m) and protein-ligand docking analysis we determined that TAM targets cyclophilin D (CypD) to inhibit mPTP formation. This results in a sustained [Ca2+]m overload upon the consequent CBD administration. Thus, TAM acting on CypD sensitizes T-ALL to mitocans such as CBD by altering the mitochondrial Ca2+ homeostasis.

Keywords: acute lymphoblastic leukemia; calcium overload; cannabidiol; cyclophilin D; mitochondria; mitochondrial permeability transition pore; tamoxifen.

MeSH terms

  • Calcium / metabolism*
  • Cannabidiol / pharmacology*
  • Cell Line, Tumor
  • Drug Synergism
  • Homeostasis / drug effects
  • Humans
  • Jurkat Cells
  • Membrane Potential, Mitochondrial / drug effects
  • Mitochondrial Permeability Transition Pore / metabolism
  • Models, Molecular
  • Molecular Docking Simulation
  • Peptidyl-Prolyl Isomerase F / chemistry
  • Peptidyl-Prolyl Isomerase F / metabolism*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
  • Protein Conformation
  • Tamoxifen / pharmacology*

Substances

  • Peptidyl-Prolyl Isomerase F
  • Mitochondrial Permeability Transition Pore
  • Tamoxifen
  • Cannabidiol
  • Calcium